Fructosamine vs A1C

Fructosamine and A1C both estimate recent blood sugar control, but they’re not interchangeable. A1C reflects your average blood glucose over roughly the past three months, based on glucose attaching to hemoglobin inside red blood cells. Fructosamine reflects a much shorter window — about the past two to three weeks — based on glucose attaching to proteins in your blood serum, mainly albumin. A1C is the test used to diagnose diabetes and prediabetes and the one most clinicians use for routine monitoring. Fructosamine isn’t used to diagnose diabetes at all; it’s a narrower tool a clinician may add when something about a person’s situation makes A1C harder to read.

This guide explains when fructosamine comes up as an alternative marker, what its limitations are, and what to bring to a visit if you’re looking at one of these results. It doesn’t tell you which test is right for you or what your specific number means — that’s a conversation for your clinician.

Terms to Know

Glycation: The process by which glucose attaches to a protein in the blood. Both A1C and fructosamine measure glycated proteins — they just measure different ones, with different turnover times.
Albumin: The main protein fructosamine measures. Albumin is replaced in the blood faster than the hemoglobin A1C relies on, which is why fructosamine reflects a shorter window.
Reference range: The span of values a lab considers typical for people without diabetes. Fructosamine ranges can vary somewhat by the performing lab, unlike A1C, which is standardized nationally.

When Might a Clinician Consider Fructosamine Instead of A1C?

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), A1C results can be thrown off by anything that changes how long red blood cells circulate. That includes recent blood loss, sickle cell disease, erythropoietin treatment, hemodialysis, and recent blood transfusion. Severe iron-deficiency anemia can falsely raise an A1C result, and kidney failure or liver disease are also cited as causes of inaccurate A1C readings.

NIDDK also notes that people of African, Mediterranean, or Southeast Asian descent, or those with family members who have sickle cell disease or thalassemia, may carry a hemoglobin variant that interferes with some A1C testing methods — often without any symptoms to signal it. A clinician may suspect this kind of interference when an A1C result doesn’t match a person’s glucose readings.

In any of these situations, a clinician may look at a marker that doesn’t depend on red blood cell lifespan — which is the role fructosamine can play. Clinical laboratory guidance describes fructosamine as useful specifically in these narrower populations, not as a general substitute for A1C in people without one of these conditions.

What Limitations Apply to Fructosamine?

It doesn’t diagnose diabetes. The Centers for Disease Control and Prevention’s list of diabetes diagnostic tests includes A1C, fasting blood sugar, the glucose tolerance test, the random blood sugar test, and autoantibody testing for type 1 diabetes. Fructosamine isn’t among them. It’s used to help monitor glucose control in people already being followed for diabetes, not to establish a diagnosis.
It can be thrown off by protein levels. Because fructosamine measures glycated serum proteins — mainly albumin — low albumin from liver disease, kidney disease, or malnutrition can make a fructosamine result read lower than a person’s actual average glucose. This is the same type of limitation A1C has with red blood cells, just tied to a different protein.
Supplements can interfere with the result. Clinical laboratory reference materials note that high levels of ascorbic acid (vitamin C) interfere with the fructosamine assay itself, and commonly advise stopping ascorbic acid supplements for at least 24 hours before the blood draw.
It’s less standardized than A1C. A1C testing is standardized nationally through the NGSP so results are comparable across labs. Fructosamine reference ranges can vary somewhat by the performing lab.
It’s a short window, not a long-term picture. A two-to-three-week average can be useful for tracking a recent change, but it doesn’t replace the longer-term view A1C provides for most people managing diabetes.

None of this makes one test “better” in general — they answer different questions over different timeframes, and a clinician weighs which question a person’s situation actually calls for.

A Result-Context Worksheet

If you’re looking at a fructosamine or A1C result and trying to make sense of it, writing down the following before your next visit gives your clinician something to work with — and keeps you from trying to interpret the number yourself:

The exact result and the units it was reported in
The date of the test and which lab performed it
The testing method or assay type, if it’s listed on the report
Any medications or supplements you’re currently taking, including ascorbic acid (vitamin C) supplements, which can affect the fructosamine test specifically
Any recent symptoms you’ve noticed, described plainly rather than self-diagnosed
Relevant health history: kidney or liver disease, anemia, or a recent blood transfusion

With that in hand, the follow-up question to bring to your clinician is simple: does this result fit what you’d expect for me, or is there something about my situation that calls for a different marker? That’s a question for your clinician to answer — not a cue to adjust anything on your own based on the number alone.

What This Guide Covers — and What It Doesn’t

This guide explains the general difference between fructosamine and A1C, when fructosamine is sometimes considered, and its known limitations. It doesn’t interpret your personal result, diagnose any condition, or recommend one test over the other for your situation. If you’re working through how to compare two results more generally — different dates, labs, or reference ranges — see A Lab Result Changed: How to Compare Dates, Units, and Reference Ranges. If you have a single result flagged outside its reference range, An Out-of-Range Lab Flag: Questions About Reference Ranges at Primary Care walks through that situation.

Discussing Testing With Your Clinician

If you’re not sure whether fructosamine, A1C, or another test fits where you are right now, that’s the conversation to have at your next visit. Bring your worksheet, name anything in your health history that might affect how a test reads, and ask directly which test — or combination — makes sense for your monitoring going forward.

If a clinician or lab has told you a result requires urgent follow-up, or you’re experiencing symptoms that feel severe or are getting worse, don’t wait on this guide — contact your clinician’s office or seek care right away. If you think you’re having a medical emergency, call your local emergency number.

This article is for general educational purposes and isn’t a substitute for professional medical advice, diagnosis, or treatment. Always talk with a qualified healthcare provider about your own test results and health needs.

Sources: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), “The A1C Test & Diabetes”; Centers for Disease Control and Prevention, “Diabetes Testing”; ARUP Laboratories test ordering reference, “Fructosamine.”

By Primary Care Visit Guide Editorial Team.